Patient Management and Clinical Recommendations during the Coronavirus (COVID-19) Pandemic. (2020, April 13). Retrieved July 17, 2021, from https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/covid-19/covidtaskforceupdate1.pdf
COVID Infection Unlikely to Jeopardize IVF Success, Small Study Suggests. (2021, June 29). Retrieved July 17, 2021, from https://www.medpagetoday.com/meetingcoverage/eshre/93335
Nelson, S. M., Yates, R. W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., . . . Fleming, R. (2008). Anti-Mullerian hormone-based approach to Controlled ovarian stimulation for assisted Conception. Human Reproduction, 24(4), 867-875.
Fertility Treatments in the Age of COVID-19: What We Know and Don't Know. (2020, April 17). Retrieved July 17, 2021, from https://www.medpagetoday.com/infectiousdisease/covid19/86019
Awwad, J., Ghazeeri, G., Toth, T., Hannoun, A., Abdallah, M. A., & Farra, C. (2012). Fever in women may interfere with follicular development during controlled ovarian stimulation. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 28(8), 742–746.
ASRM and SART's FAQs Related to COVID-19. (2021, January 22). Retrieved July 17, 2021, from https://www.reproductivefacts.org/faqs/faqs-related-to-covid-19
Join our Newsletter for charting tips, updates and offers.